USPTO serial 97842069
EPISCORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 26, 2024
- Examiner
- JOHNSON, CLINTON J
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EPISCORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Sheehan Anderson
Jennifer Sheehan Anderson BRIDGE INTELLECTUAL PROPERTY SERVICES PLLC143 CADYCENTER, SUITE 209NORTHVILLE, MI 48167United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic test kits for medical and clinical use comprised of medical diagnostic reagents for use in identifying and measuring changes associated with cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease; medical diagnostic assay kits comprised of medical diagnostic reagents for use in identifying and measuring changes associated with cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease in the field of cancer detection, detection of or chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease; diagnostic reagents for medical purposes | ACTIVE | — |
| 010 | Medical apparatus for medical diagnostic testing in the fields of cancer and chronic obstructive pulmonary disease (COPD) | ACTIVE | — |
| 044 | Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease and prognosis of expected progression of the diseases; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease; providing cancer screening services; providing medical screening services for chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease; providing a website featuring information in the fields of the diagnosis and treatment of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nucleix Limited
- Other trademarks owned by Nucleix Limited
- Other trademarks owned by Nucleix Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named EPISCORE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 26, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 26, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 19, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 18, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 18, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 17, 2024 | ALIE | ASSIGNED TO LIE | — |
| Mar 4, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 13, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 20, 2023 | NWAP | NEW APPLICATION ENTERED | — |